-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: November 2012
When it Comes to Patients, There is No Average
Next month, the National Pharmaceutical Council will host a forum — which BIO is cosponsoring — that will focus on the unique differences among treatment effects in individual patients and how policymakers, payers, and providers could shape programs and policies to acknowledge those differences. The forum, “The Myth of Average: Why Individual Patient Differences Matter” is taking place on November 30 at the Omni Shoreham Hotel in Washington, D.C. More information and registration materials are available Read More >
Academics to be Featured at the 2013 BIO Alliance Pavilion
I think it safe to say that the U.S. biotechnology industry has its R&D roots in the laboratories of great research universities with great science and visionary researchers. These cutting-edge, biology-based research and industry commercialization efforts continue to be the key drivers in moving invention into innovation to heal, fuel and feed the world. Because of this essential knowledge-driven relationship, the 2013 BIO International Convention will again bring together academic and research colleagues to focus Read More >
Flight Flies on 100 Percent Biofuels
This week saw the first-ever completely biofuel-powered flight take place. The National Research Council of Canada conducted the first flight on 100 percent renewable, drop-in biofuel on its Falcon 20 jet, according to oilprice.com, marking a huge milestone for the aviation and renewable energy industries. Oilseed crops commercialized by Agrisoma were used as a feedstock and transformed by Applied Research Associates into a complete replacement fuel for conventional jet fuel. Previously, flights on biofuels had Read More >
SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan
The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual property, especially patent rights. Patent protection is territorial, and patent practice varies in different jurisdictions. Many foreign biotech companies continue to look at China as an important emerging market, and they increasingly file patent applications in China to develop their global patent portfolios. At the same time, China has made biotechnology one of the eight strategic new technology focuses in Read More >
